GnRH glycs PPD vaccine - ProthericsAlternative Names: GnRH glycs PPD
Latest Information Update: 16 Jul 2002
At a glance
- Originator Protherics
- Class Hormones; Vaccines
- Mechanism of Action Gonadotropin releasing hormone inhibitors; Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 16 Jul 2002 Discontinued - Preclinical for Breast cancer in United Kingdom (Intraperitoneal)
- 21 Oct 1999 Proteus International has merged with Therapeutic Antibodies to form Protherics
- 16 Oct 1997 New profile